Summit Therapeutics Inc.
SMMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$221 | -$615 | -$79 | -$89 |
| Dep. & Amort. | $0 | $2 | $3 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $51 | $14 | $10 | $9 |
| Change in WC | $15 | -$2 | $9 | -$0 |
| Other Non-Cash | $13 | $524 | $14 | $0 |
| Operating Cash Flow | -$142 | -$77 | -$42 | -$73 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$680 | -$321 | $0 | $0 |
| Inv. Sales/Matur. | $490 | $208 | $0 | $0 |
| Other Inv. Act. | -$15 | -$475 | -$0 | $0 |
| Investing Cash Flow | -$205 | -$588 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$100 | -$25 | $520 | $0 |
| Stock Issued | $478 | $5 | $100 | $75 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $106 | $100 | $3 |
| Financing Cash Flow | $381 | $87 | $620 | $78 |
| Forex Effect | -$0 | $1 | -$1 | $0 |
| Net Chg. in Cash | $34 | -$577 | $577 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71 | $649 | $72 | $66 |
| End Cash | $105 | $71 | $649 | $72 |
| Free Cash Flow | -$142 | -$77 | -$42 | -$73 |